Product
Elelyso
1 clinical trial
2 indications
Indication
Gaucher's DiseaseIndication
Type IIIClinical trial
A Multicenter, Safety and Efficacy Study of Taliglucerase Alfa in Subjects With Type 3 Gaucher DiseaseStatus: Completed, Estimated PCD: 2023-07-30